Bill

Bill > S3128


NJ S3128

Requires health benefits plans to cover abuse-deterrent opioid analgesic drug products.


summary

Introduced
04/15/2024
In Committee
04/15/2024
Crossed Over
Passed
Dead

Introduced Session

2024-2025 Regular Session

Bill Summary

This bill requires health benefits plans to cover abuse-deterrent analgesic opioid drug products. Under the bill, a carrier will be required to provide coverage and benefits, on its prescription drug formulary list, for at least one abuse-deterrent opioid analgesic drug product per opioid analgesic active ingredient. The bill also provides that cost-sharing for a brand name or generic abuse-deterrent opioid analgesic drug product is not to exceed the lowest cost-sharing amount applied to a brand name or generic non-abuse deterrent opioid drug, respectively. Finally, the bill provides that any prior-authorization requirements or other utilization review requirements for an opioid analgesic, and any service denials made thereunder, are prohibited from requiring a covered person or enrollee to use an opioid analgesic drug product without abuse-deterrent properties before a covered person or enrollee can access an abuse-deterrent opioid analgesic drug product.

AI Summary

This bill requires health benefits plans in New Jersey to cover at least one abuse-deterrent opioid analgesic drug product per opioid analgesic active ingredient. It also limits the cost-sharing for brand-name and generic abuse-deterrent opioid analgesic drug products to the lowest cost-sharing amount applied to non-abuse deterrent opioid drugs. Additionally, the bill prohibits prior-authorization or other utilization review requirements from requiring the use of opioid analgesic drug products without abuse-deterrent properties before accessing abuse-deterrent opioid analgesic drug products. The bill defines key terms such as "abuse-deterrent opioid analgesic drug product," "carrier," "cost-sharing," and "opioid analgesic drug product." The bill takes effect 90 days after enactment and applies to policies and contracts delivered, issued, executed, or renewed on or after that date.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 04/15/2024)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...